THE USE OF ANTI-BETA-2GPI ASSAY FOR DISCRIMINATION BETWEEN ANTICARDIOLIPIN ANTIBODIES ASSOCIATED WITH INFECTION AND INCREASED RISK OF THROMBOSIS